Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Laurent Jacquin, Frédéric Franceschi, Youlet By, Josée-Martine Durand-Gorde, Jocelyne Condo, Jean-Claude Deharo, Pierre Michelet, Emmanuel Fenouillet, Régis Guieu, Jean Ruf
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1146/annurev.pa.35.040195.003053
10.1146/annurev.pa.35.040195.003053
10.1007/s00395-008-0737-9
10.1007/s00395-008-0737-9
10.1152/ajpheart.00819.2007
10.1152/ajpheart.00819.2007
10.1016/j.ejphar.2008.08.002
10.1016/j.ejphar.2008.08.002
10.1146/annurev.pharmtox.45.120403.095731
10.1146/annurev.pharmtox.45.120403.095731
10.1002/jnr.21071
10.1002/jnr.21071
10.1038/nrd2638
10.1038/nrd2638
10.1016/j.pharmthera.2005.04.013
10.1016/j.pharmthera.2005.04.013
10.1007/978-1-4684-1248-2_2
10.1007/978-1-4684-1248-2_2
10.1007/bf02591429
10.1007/bf02591429
Selective modulation of antibody response and natural killer cell activity by purine nucleoside analogues
1988
Adenosine receptors and modulation of natural killer cell activity by purine nucleosides
1990
10.1016/0008-8749(90)90208-9
10.1016/0008-8749(90)90208-9
10.1016/0008-8749(90)90291-x
10.1016/0008-8749(90)90291-x
10.1093/intimm/11.2.179
10.1093/intimm/11.2.179
10.1124/mol.104.009225
10.1124/mol.104.009225
10.1124/mol.65.3.711
10.1124/mol.65.3.711
10.1182/blood.v90.4.1600
10.1182/blood.v90.4.1600
Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)
2008
Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies
10.1016/s0026-895x(24)12188-8 · 1999
10.1242/jcs.112.4.491
10.1242/jcs.112.4.491
10.1111/j.1600-065x.1995.tb00680.x
10.1111/j.1600-065x.1995.tb00680.x
10.1182/blood.v95.12.3859
10.1182/blood.v95.12.3859
10.1182/blood-2004-04-1407
10.1182/blood-2004-04-1407
10.4049/jimmunol.174.2.1073
10.4049/jimmunol.174.2.1073
10.1161/circulationaha.106.649244
10.1161/circulationaha.106.649244
10.1096/fj.08-107458
10.1096/fj.08-107458
10.1096/fj.10-155192
10.1096/fj.10-155192
10.1084/jem.20062512
10.1084/jem.20062512
10.1016/j.it.2008.12.002
10.1016/j.it.2008.12.002
10.1111/j.1476-5381.1956.tb00006.x
10.1111/j.1476-5381.1956.tb00006.x
10.1073/pnas.072673899
10.1073/pnas.072673899
10.1161/01.cir.98.7.711
10.1161/01.cir.98.7.711
10.1042/bj3540123
10.1042/bj3540123
10.1016/j.molimm.2008.10.017
10.1016/j.molimm.2008.10.017
10.1161/01.cir.0000023924.66889.4c
10.1161/01.cir.0000023924.66889.4c
10.1016/j.hrthm.2007.03.002
10.1016/j.hrthm.2007.03.002
10.1136/heartjnl-2011-301411
10.1136/heartjnl-2011-301411
10.1081/jlc-100101769
10.1081/jlc-100101769
10.1096/fj.02-0543fje
10.1096/fj.02-0543fje
10.1096/fj.11-188961
10.1096/fj.11-188961 · doi-reference
10.1016/j.tins.2007.11.007
10.1016/j.tins.2007.11.007 · doi-reference
10.1093/eurheartj/ehp126
10.1093/eurheartj/ehp126 · doi-reference
10.4049/jimmunol.170.3.1224
10.4049/jimmunol.170.3.1224 · doi-reference
10.2310/6650.2006.06005
10.2310/6650.2006.06005 · doi-reference
10.1016/j.humimm.2010.08.010
10.1016/j.humimm.2010.08.010 · doi-reference
10.1016/j.acvd.2008.09.005
10.1016/j.acvd.2008.09.005 · doi-reference